Serbia First in Europe to Participate in Phase 3 Clinical Trial of Lung Cancer Vaccine | Health Informer »
Posted By Varadinum 11 months, 1 week ago in Health & FitnessNovaRx Corporation announced the opening of the companys pivotal Phase 3 clinical trial of Lucanix(R) (belagenpumatucel-L) in the treatment of advanced non-small cell lung cancer (NSCLC) in Serbia. Serbian oncology centers participating in the trial include the Clinical Hospital Center Benzanijska Kosa in Belgrade, the Clinic for Pulmonary Diseases and TB Knez Selo in Nis, and the Institute for Pulmonary Disease of Vojvodina in Sremska Kamenica.
Read Full Story at healthinformer.net »
698 Views Share Story 0 Comments Report
Submitted By:
Varadinum
I appreciate PROPELLER very much
It is a great place to find high-quality content.
Add a Comment
Sign In With Your Propeller Account
Please keep your comments relevant to this story.
To create a live link, simply type the URL (including http://) or email address and we will make it a live link for you. You can put up to 3 URLs in your comments. Line breaks and paragraphs are automatically converted — no need to use <p> or <br /> tags.